Erschienen in:
04.11.2019 | Review Article
Experience of Immune Tolerance Induction Therapy for Hemophilia A Patients with Inhibitors from a Single Center in India
verfasst von:
Tulika Seth
Erschienen in:
Indian Journal of Hematology and Blood Transfusion
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Abstract
The availability of clotting factor concentrates of both factor VIII and factor IX have improved hemophilia treatment to a great extent. Many more improvements like physiotherapy, and comprehensive care are needed to give better care. One important complication that occurs, but is often set aside is the development of inhibitors. When an inhibitor develops in a patient of severe hemophilia then the care becomes more difficult and expensive. Eradication of the inhibitor is possible by Immune tolerance induction (ITI), this paper explains some important essential factors and practical issues during my experience with ITI.